BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23304015)

  • 21. [Essential thrombocytosis].
    Van Camp G
    Acta Clin Belg; 1989; 44(1):31-6. PubMed ID: 2763782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythromelalgia as a presenting manifestation in a patient with essential thrombocythemia complicating renovascular hypertension due to unilateral renal artery stenosis.
    Hur JW; Lee YY; Lee WS; Jun JB
    Rheumatol Int; 2005 Nov; 26(1):83-5. PubMed ID: 15750823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Portal vein thrombosis associated with essential thrombocytosis. Clinical cases and review of the literature].
    Carvajal S; Zapata R; Bertín P; Miquel JF
    Rev Med Chil; 1996 Mar; 124(3):353-8. PubMed ID: 9008949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined plateletpheresis and cytotoxic chemotherapy for symptomatic thrombocytosis in myeloproliferative disorders.
    Baron BW; Mick R; Baron JM
    Cancer; 1993 Aug; 72(4):1209-18. PubMed ID: 8339212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of thrombocytosis by plateletpheresis using a cell separator.
    Beard ME; Blacklock HA; Varcoe AR
    N Z Med J; 1980 Feb; 91(654):136-8. PubMed ID: 6929973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vascular complications of essential thrombocythemia].
    Bellucci S
    Bull Acad Natl Med; 2007 Mar; 191(3):519-30; discussion 530-3. PubMed ID: 18072651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
    Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH
    Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydroxyurea in essential thrombocytosis.
    Van Genderen PJ; Michiels JJ
    N Engl J Med; 1995 Sep; 333(12):802-3. PubMed ID: 7643898
    [No Abstract]   [Full Text] [Related]  

  • 29. Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia.
    Michiels JJ; Abels J; Steketee J; van Vliet HH; Vuzevski VD
    Ann Intern Med; 1985 Apr; 102(4):466-71. PubMed ID: 3977194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
    Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W
    Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Essential thrombocythemia as a cause of headache in young woman].
    Bieniaszewska M; Balon J; Hellmann A
    Pol Merkur Lekarski; 2000 Jul; 8(49):479-80. PubMed ID: 11070720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do we need antiplatelet therapy in thrombocytosis? Contra. Proposal for an individualized risk-adapted treatment.
    Scharf RE
    Hamostaseologie; 2016 Nov; 36(4):241-260. PubMed ID: 27414763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Essential thrombocytosis: diagnostic and treatment dilemmas.
    Dugan V; Higginbotham R; Gilbert J; Lipscomb G; Lopez FA
    J La State Med Soc; 2003; 155(6):306-13. PubMed ID: 14750750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic thrombocytapheresis for extreme thrombocytosis after chemotherapy in essential thrombocytosis.
    Almeida-Dias R; Garrote M; Cid J; Mustieles MJ; Alba C; Lozano M
    J Clin Apher; 2019 Aug; 34(4):503-506. PubMed ID: 30624802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anagrelide: 20 years later.
    Emadi A; Spivak JL
    Expert Rev Anticancer Ther; 2009 Jan; 9(1):37-50. PubMed ID: 19105705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombotic and hemorrhagic complications in chronic myeloproliferative disorders.
    Sagripanti A; Ferretti A; Nicolini A; Carpi A
    Biomed Pharmacother; 1996; 50(8):376-82. PubMed ID: 8952859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The rate of progression to polycythemia vera or essential thrombocythemia in patients with erythrocytosis or thrombocytosis.
    Ruggeri M; Tosetto A; Frezzato M; Rodeghiero F
    Ann Intern Med; 2003 Sep; 139(6):470-5. PubMed ID: 13679323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet hyperaggregability and thrombosis in patients with thrombocythemia.
    Wu KK
    Ann Intern Med; 1978 Jan; 88(1):7-11. PubMed ID: 619762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sticky platelet syndrome and thrombocythemia.
    Frenkel EP; Mammen EF
    Hematol Oncol Clin North Am; 2003 Feb; 17(1):63-83. PubMed ID: 12627663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythromelalgic, thrombotic and haemorrhagic manifestations of thrombocythaemia.
    van Genderen PJ; Michiels JJ
    Presse Med; 1994 Jan; 23(2):73-7. PubMed ID: 8140075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.